Ost-müük Roche Holding AG - ROGz CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 1.2 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.014885% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | -0.007337% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | CHF | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | Switzerland | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Roche Holding AG ESG Risk Ratings
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
Eelmine sulgemine* | 288.2 |
Avatud* | 288.8 |
Aastane muutus* | -12.56% |
Päeva ulatus* | 283.8 - 290.4 |
52 nädala ulatus | 256.05-335.85 |
Keskmine maht (10 päeva) | 1.56M |
Keskmine maht (3 kuud) | 27.98M |
Turukapitalisatsioon | 235.23B |
P/E suhtarv | 18.77 |
Ringluses olevad aktsiad | 799.18M |
Tulu | 63.28B |
EPS | 15.36 |
Dividendid (% kasumist) | 3.29632 |
Beeta | 0.76 |
Järgmine tuluaruande kuupäev | Jul 27, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
May 31, 2023 | 284.1 | -5.0 | -1.73% | 289.1 | 290.6 | 280.8 |
May 30, 2023 | 288.2 | -0.9 | -0.31% | 289.1 | 290.2 | 286.7 |
May 26, 2023 | 290.7 | 1.6 | 0.55% | 289.1 | 291.2 | 286.7 |
May 25, 2023 | 287.4 | 0.8 | 0.28% | 286.6 | 288.7 | 285.9 |
May 24, 2023 | 288.2 | 1.2 | 0.42% | 287.0 | 288.8 | 286.3 |
May 23, 2023 | 285.8 | 0.4 | 0.14% | 285.4 | 287.8 | 284.5 |
May 22, 2023 | 285.7 | -1.8 | -0.63% | 287.5 | 288.4 | 283.9 |
May 19, 2023 | 287.1 | 2.1 | 0.74% | 285.0 | 288.7 | 283.9 |
May 17, 2023 | 283.5 | 1.4 | 0.50% | 282.1 | 284.5 | 281.9 |
May 16, 2023 | 281.6 | -1.7 | -0.60% | 283.3 | 284.0 | 280.8 |
May 15, 2023 | 284.2 | -0.7 | -0.25% | 284.9 | 285.5 | 283.1 |
May 12, 2023 | 283.9 | 2.0 | 0.71% | 281.9 | 284.9 | 281.9 |
May 11, 2023 | 281.5 | 1.0 | 0.36% | 280.5 | 283.1 | 280.4 |
May 10, 2023 | 280.2 | -1.8 | -0.64% | 282.0 | 282.0 | 278.8 |
May 9, 2023 | 282.9 | -1.1 | -0.39% | 284.0 | 284.5 | 281.0 |
May 8, 2023 | 283.7 | 0.3 | 0.11% | 283.4 | 285.0 | 282.8 |
May 5, 2023 | 282.8 | 1.4 | 0.50% | 281.4 | 282.9 | 279.9 |
May 4, 2023 | 281.4 | 1.9 | 0.68% | 279.5 | 281.6 | 278.8 |
May 3, 2023 | 280.4 | -0.4 | -0.14% | 280.8 | 281.2 | 277.1 |
May 2, 2023 | 279.9 | -3.0 | -1.06% | 282.9 | 283.0 | 279.4 |
Roche Holding AG Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
Wednesday, June 7, 2023 | ||
Kellaaeg (UTC) (UTC) 12:00 | Riik CH
| Sündmus Roche Holding AG at Jefferies Healthcare Conference Roche Holding AG at Jefferies Healthcare ConferenceForecast -Previous - |
Thursday, June 8, 2023 | ||
Kellaaeg (UTC) (UTC) 06:00 | Riik CH
| Sündmus Roche Holding AG at Exane CEO Conference Roche Holding AG at Exane CEO ConferenceForecast -Previous - |
Monday, June 12, 2023 | ||
Kellaaeg (UTC) (UTC) 14:30 | Riik CH
| Sündmus Roche Holding AG Virtual EHA 2023 Event: Crovalimab in Hematology and Nephrology Roche Holding AG Virtual EHA 2023 Event: Crovalimab in Hematology and NephrologyForecast -Previous - |
Wednesday, June 14, 2023 | ||
Kellaaeg (UTC) (UTC) 12:00 | Riik CH
| Sündmus Roche Holding AG at Stifel Swiss Equities Conference Roche Holding AG at Stifel Swiss Equities ConferenceForecast -Previous - |
Kellaaeg (UTC) (UTC) 15:00 | Riik CH
| Sündmus Roche Holding AG at Goldman Sachs Healthcare Conference Roche Holding AG at Goldman Sachs Healthcare ConferenceForecast -Previous - |
Tuesday, June 20, 2023 | ||
Kellaaeg (UTC) (UTC) 07:00 | Riik CH
| Sündmus Roche Holding AG at Citi European Healthcare Conference Roche Holding AG at Citi European Healthcare ConferenceForecast -Previous - |
Wednesday, June 21, 2023 | ||
Kellaaeg (UTC) (UTC) 08:00 | Riik CH
| Sündmus Roche Holding AG at Deutsche Bank dbAccess German Swiss Austrian Conference Roche Holding AG at Deutsche Bank dbAccess German Swiss Austrian ConferenceForecast -Previous - |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kogutulu | 63281 | 62801 | 58323 | 61466 | 56846 |
Tulu | 63281 | 62801 | 58323 | 61466 | 56846 |
Kulud, Kokku | 18511 | 19348 | 15900 | 17377 | 16445 |
Brutokasum | 44770 | 43453 | 42423 | 44089 | 40401 |
Kogu tegevuskulu | 45805 | 44646 | 39780 | 43918 | 42077 |
Müük/Üldine/admin kulud, kokku | 12124 | 12100 | 12075 | 13208 | 12453 |
Uuringud ja arendus | 14050 | 13707 | 12151 | 11690 | 11048 |
Depreciation / Amortization | 378 | 351 | 446 | 268 | 183 |
Ootamatud kulutused (tulu) | 2569 | 376 | 426 | 2677 | 3945 |
Other Operating Expenses, Total | -1827 | -1236 | -1218 | -1302 | -1997 |
Tulud majandustegevusest | 17476 | 18155 | 18543 | 17548 | 14769 |
Intressitulud (kulu), muud tulud, neto | -1040 | -677 | -463 | -758 | -419 |
Muud, neto | -109 | -80 | -115 | -176 | -202 |
Netotulu enne makse | 16327 | 17398 | 17965 | 16614 | 14148 |
Netotulu pärast makse | 13531 | 14935 | 15068 | 14108 | 10830 |
Vähemuse intress | -1110 | -1005 | -773 | -611 | -365 |
Netotulu enne erikulusid | 12421 | 13930 | 14295 | 13497 | 10465 |
Netotulu | 12421 | 13930 | 14295 | 13497 | 10500 |
Arvestatav tulu, v a erikulud | 12421 | 13930 | 14295 | 13497 | 10465 |
Arvestatav tulu, koos erikuludega | 12421 | 13930 | 14295 | 13497 | 10500 |
Jaotuse korrigeerimine | -1 | -1 | -1 | -2 | -1 |
Jaotamisele kuuluv netotulu | 12420 | 13929 | 14294 | 13495 | 10499 |
Keskmine jaotamisele kuuluv aktsia kohta | 808 | 860 | 865 | 864 | 860 |
Jaotatav EPS, v a erakorralised kulud | 15.3713 | 16.1965 | 16.5249 | 15.6192 | 12.1674 |
Dividends per Share - Common Stock Primary Issue | 9.5 | 9.3 | 9.1 | 9 | 8.7 |
Jaotamisele kuuluv normaal-EPS | 17.9847 | 16.5778 | 16.9515 | 18.2807 | 15.702 |
Erakorralised kulud kokku | 35 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|
Kogutulu | 30986 | 32295 | 32088 | 30713 |
Tulu | 30986 | 32295 | 32088 | 30713 |
Kulud, Kokku | 8949 | 9562 | 10279 | 9069 |
Brutokasum | 22037 | 22733 | 21809 | 21644 |
Kogu tegevuskulu | 25057 | 20748 | 24010 | 20636 |
Müük/Üldine/admin kulud, kokku | 6479 | 5645 | 6544 | 5556 |
Uuringud ja arendus | 7422 | 6628 | 7017 | 6690 |
Depreciation / Amortization | 196 | 182 | 177 | 174 |
Ootamatud kulutused (tulu) | 2584 | -15 | 619 | -243 |
Other Operating Expenses, Total | -573 | -1254 | -626 | -610 |
Tulud majandustegevusest | 5929 | 11547 | 8078 | 10077 |
Intressitulud (kulu), muud tulud, neto | -568 | -472 | -524 | -151 |
Muud, neto | -19 | -90 | -43 | -39 |
Netotulu enne makse | 5342 | 10985 | 7511 | 9887 |
Netotulu pärast makse | 4370 | 9161 | 6719 | 8216 |
Vähemuse intress | -479 | -631 | -592 | -413 |
Netotulu enne erikulusid | 3891 | 8530 | 6127 | 7803 |
Netotulu | 3891 | 8530 | 6127 | 7803 |
Arvestatav tulu, v a erikulud | 3891 | 8530 | 6127 | 7803 |
Arvestatav tulu, koos erikuludega | 3891 | 8530 | 6127 | 7803 |
Jaotuse korrigeerimine | -1 | 0 | -1 | 0 |
Jaotamisele kuuluv netotulu | 3890 | 8530 | 6126 | 7803 |
Keskmine jaotamisele kuuluv aktsia kohta | 806 | 810 | 858 | 862 |
Jaotatav EPS, v a erakorralised kulud | 4.8263 | 10.5309 | 7.13986 | 9.0522 |
Dividends per Share - Common Stock Primary Issue | 9.5 | 0 | 9.3 | 0 |
Jaotamisele kuuluv normaal-EPS | 7.42355 | 10.5195 | 7.78732 | 8.8218 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Käibevarad kokku | 33816 | 35627 | 32942 | 31254 | 32244 |
Raha ja lühiajalised investeeringud | 9767 | 13031 | 12334 | 11858 | 13118 |
Cash | 2841 | 5028 | 4536 | 4769 | 4139 |
Raha ja ekvivalendid | 2150 | 1822 | 1191 | 1306 | 2542 |
Lühiajalised investeeringud | 4776 | 6181 | 6607 | 5783 | 6437 |
Laekumata arved, neto | 13866 | 12651 | 11740 | 12150 | 11487 |
Accounts Receivable - Trade, Net | 11527 | 10719 | 10056 | 10343 | 9687 |
Total Inventory | 8605 | 7715 | 7194 | 6055 | 6621 |
Prepaid Expenses | 1202 | 1869 | 1153 | 795 | 683 |
Other Current Assets, Total | 376 | 361 | 521 | 396 | 335 |
Total Assets | 88151 | 92317 | 86138 | 83091 | 78517 |
Property/Plant/Equipment, Total - Net | 24208 | 24412 | 23270 | 23318 | 21818 |
Property/Plant/Equipment, Total - Gross | 49408 | 48205 | 45664 | 45041 | 41822 |
Accumulated Depreciation, Total | -25200 | -23793 | -22394 | -21723 | -20004 |
Goodwill, Net | 10820 | 10809 | 9249 | 12456 | 8948 |
Intangibles, Net | 9685 | 12117 | 12017 | 8358 | 9346 |
Long Term Investments | 971 | 1069 | 1276 | 739 | 602 |
Note Receivable - Long Term | 125 | 133 | 125 | 128 | 132 |
Other Long Term Assets, Total | 8526 | 8150 | 7259 | 6838 | 5427 |
Total Current Liabilities | 27239 | 38416 | 25401 | 24119 | 23033 |
Accounts Payable | 3861 | 3844 | 3317 | 3176 | 2847 |
Accrued Expenses | 12180 | 12497 | 11205 | 11214 | 10676 |
Notes Payable/Short Term Debt | 2191 | 14618 | 2189 | 1694 | 722 |
Current Port. of LT Debt/Capital Leases | 2071 | 833 | 2126 | 341 | 1971 |
Other Current Liabilities, Total | 6936 | 6624 | 6564 | 7694 | 6817 |
Total Liabilities | 60159 | 67828 | 49797 | 50344 | 50895 |
Total Long Term Debt | 22282 | 17101 | 11096 | 13547 | 16077 |
Long Term Debt | 21391 | 16076 | 10220 | 12668 | 16075 |
Capital Lease Obligations | 891 | 1025 | 876 | 879 | 2 |
Deferred Income Tax | 645 | 628 | 353 | 298 | 384 |
Minority Interest | 4023 | 3856 | 3432 | 3120 | 2744 |
Other Liabilities, Total | 5970 | 7827 | 9515 | 9260 | 8657 |
Total Equity | 27992 | 24489 | 36341 | 32747 | 27622 |
Common Stock | 107 | 160 | 160 | 160 | 160 |
Retained Earnings (Accumulated Deficit) | 38937 | 34161 | 45571 | 40524 | 34935 |
Unrealized Gain (Loss) | -59 | -60 | 106 | 15 | 28 |
Other Equity, Total | -10993 | -9772 | -9496 | -7952 | -7501 |
Total Liabilities & Shareholders’ Equity | 88151 | 92317 | 86138 | 83091 | 78517 |
Total Common Shares Outstanding | 799.181 | 800.403 | 853.126 | 855.756 | 854.428 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|
Käibevarad kokku | 33816 | 30321 | 35627 | 31260 |
Raha ja lühiajalised investeeringud | 9767 | 6808 | 13031 | 8017 |
Raha ja ekvivalendid | 4991 | 4315 | 6850 | 5000 |
Lühiajalised investeeringud | 4776 | 2493 | 6181 | 3017 |
Laekumata arved, neto | 11919 | 11078 | 11126 | 11809 |
Accounts Receivable - Trade, Net | 11606 | 10809 | 10806 | 11656 |
Total Inventory | 8605 | 8292 | 7715 | 8319 |
Other Current Assets, Total | 3525 | 4143 | 3755 | 3115 |
Total Assets | 88151 | 86736 | 92317 | 87887 |
Property/Plant/Equipment, Total - Net | 24208 | 24324 | 24412 | 24300 |
Goodwill, Net | 10820 | 11160 | 10809 | 10623 |
Intangibles, Net | 9685 | 11735 | 12117 | 12510 |
Other Long Term Assets, Total | 9622 | 9196 | 9352 | 9194 |
Total Current Liabilities | 27239 | 27409 | 38416 | 25193 |
Payable/Accrued | 4556 | 3896 | 4637 | 4241 |
Notes Payable/Short Term Debt | 2191 | 2976 | 14618 | 2530 |
Current Port. of LT Debt/Capital Leases | 1769 | 2405 | 504 | 1196 |
Other Current Liabilities, Total | 18723 | 18132 | 18657 | 17226 |
Total Liabilities | 60159 | 61547 | 67828 | 50073 |
Total Long Term Debt | 21391 | 22369 | 16076 | 11285 |
Long Term Debt | 21391 | 22369 | 16076 | 11285 |
Deferred Income Tax | 645 | 690 | 628 | 499 |
Minority Interest | 4023 | 3757 | 3856 | 3619 |
Other Liabilities, Total | 6861 | 7322 | 8852 | 9477 |
Total Equity | 27992 | 25189 | 24489 | 37814 |
Common Stock | 107 | 107 | 160 | 160 |
Retained Earnings (Accumulated Deficit) | 38937 | 35740 | 34161 | 46686 |
Unrealized Gain (Loss) | -59 | -151 | -60 | -90 |
Other Equity, Total | -10993 | -10507 | -9772 | -8942 |
Total Liabilities & Shareholders’ Equity | 88151 | 86736 | 92317 | 87887 |
Total Common Shares Outstanding | 799.181 | 800.579 | 800.403 | 854.261 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Netotulu/algväärtus | 13531 | 14935 | 15068 | 14108 | 10865 |
Raha majandustegevusest | 18415 | 20976 | 18566 | 22385 | 19979 |
Raha majandustegevusest | 2906 | 2887 | 2808 | 2760 | 2292 |
Amortization | 938 | 1556 | 1750 | 1532 | 1294 |
Mittelikviidsed varad | 9267 | 7718 | 6227 | 8883 | 10308 |
Cash Taxes Paid | 4102 | 3343 | 3236 | 3543 | 3288 |
Makstud intressid | 557 | 407 | 422 | 624 | 593 |
Muutused tööjõus | -8227 | -6120 | -7287 | -4898 | -4780 |
Tulu investeeringutelt | -3536 | -6552 | -9067 | -8634 | -7195 |
Kapitalikulutused | -4797 | -4652 | -7858 | -4896 | -6746 |
Muud rahavood investeeringutelt, kokku | 1261 | -1900 | -1209 | -3738 | -449 |
Rahavood investeeringutelt | -16275 | -13108 | -9666 | -14173 | -10691 |
Rahavoogudesse investeerimine | -2340 | -2333 | -1992 | -1716 | -3316 |
Total Cash Dividends Paid | -7832 | -8132 | -7964 | -7682 | -7253 |
Laenu väljastamine (kustutamine), neto | -6103 | 16348 | 290 | -4775 | -122 |
Muutused valuutakursside kõikumisest | -463 | -193 | -181 | -184 | -131 |
Rahaline kogumuutus | -1859 | 1123 | -348 | -606 | 1962 |
Aktsiate emiteerimine (tagasiost), neto | 0 | -18991 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|
Net income/Starting Line | 13531 | 9161 | 14935 | 8216 |
Cash From Operating Activities | 18415 | 9509 | 20976 | 8212 |
Cash From Operating Activities | 2906 | 1429 | 2887 | 1439 |
Amortization | 938 | 471 | 1556 | 830 |
Non-Cash Items | 9267 | 3799 | 7718 | 3323 |
Cash Taxes Paid | 4102 | 2482 | 3343 | 2183 |
Cash Interest Paid | 557 | 228 | 407 | 243 |
Changes in Working Capital | -8227 | -5351 | -6120 | -5596 |
Cash From Investing Activities | -3536 | 1473 | -6552 | 44 |
Capital Expenditures | -4797 | -2067 | -4652 | -2197 |
Other Investing Cash Flow Items, Total | 1261 | 3540 | -1900 | 2241 |
Cash From Financing Activities | -16275 | -13315 | -13108 | -9056 |
Financing Cash Flow Items | -2340 | -1374 | -2333 | -1211 |
Total Cash Dividends Paid | -7832 | -7672 | -8132 | -7955 |
Issuance (Retirement) of Debt, Net | -6103 | -4269 | 16348 | 110 |
Foreign Exchange Effects | -463 | -202 | -193 | 73 |
Net Change in Cash | -1859 | -2535 | 1123 | -727 |
Issuance (Retirement) of Stock, Net | 0 | -18991 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.1079 | 21834628 | 173085 | 2023-04-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.8532 | 20045265 | 2208289 | 2022-12-31 | LOW |
UBS Asset Management (Switzerland) | Investment Advisor | 1.8605 | 13071428 | -86601 | 2023-04-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.8316 | 12868041 | 71688 | 2023-04-30 | LOW |
Credit Suisse Asset Management | Investment Advisor/Hedge Fund | 1.667 | 11711936 | 8879 | 2023-04-30 | LOW |
MFS Investment Management | Investment Advisor/Hedge Fund | 1.5309 | 10755461 | 141764 | 2023-04-30 | LOW |
Zürcher Kantonalbank (Asset Management) | Bank and Trust | 1.239 | 8704542 | 83328 | 2023-04-30 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.9971 | 7005557 | -46636 | 2023-04-30 | LOW |
Fidelity International | Investment Advisor | 0.8201 | 5761424 | 114439 | 2023-03-31 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.6721 | 4722004 | 7988 | 2023-04-30 | LOW |
Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 0.6581 | 4623374 | -19085 | 2023-03-31 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 0.6181 | 4342654 | -1572740 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.6015 | 4226034 | 30 | 2023-04-30 | LOW |
Dodge & Cox | Investment Advisor/Hedge Fund | 0.5908 | 4150400 | 75100 | 2023-03-31 | LOW |
California Public Employees' Retirement System | Pension Fund | 0.5839 | 4102151 | -453583 | 2022-06-30 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 0.5297 | 3721580 | -1515868 | 2023-04-30 | MED |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.5147 | 3616071 | -2492 | 2023-04-30 | LOW |
RBC Global Asset Management (UK) Limited | Investment Advisor | 0.4154 | 2918253 | -77338 | 2023-04-30 | LOW |
PRIMECAP Management Company | Investment Advisor | 0.3704 | 2602358 | -25668 | 2023-03-31 | LOW |
Mawer Investment Management Ltd. | Investment Advisor | 0.3591 | 2522750 | 367 | 2023-03-31 | LOW |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group530K+
Kauplejad
87K+
Igakuiste aktiivsete klientide arv
$46M+
Igakuine investeerimise maht
$31M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Roche Company profile
Ettevõttest Roche Holding AG
Roche Holding AG (edaspidi "Roche") on teadusuuringutega tegelev tervishoiuettevõte. Ettevõtte tegevusvaldkonnad on jaotatud kahte divisjoni: Farmaatsiatooted ja diagnostika. Farmaatsiatoodete divisjon koosneb kahest ärisegmendist: Roche Pharmaceuticals ja Chugai. Diagnostika divisjon koosneb neljast ärivaldkonnast: Diabeediravi, molekulaardiagnostika, professionaalne diagnostika ja koediagnostika. Ettevõte arendab ravimeid erinevate haigusvaldkondade jaoks, sealhulgas onkoloogia, immunoloogia, nakkushaigused, oftalmoloogia ja neuroteadus. Ettevõtte ravimite hulka kuuluvad Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin ja Roferon-A. Ettevõte pakub tooteid teadlastele, sealhulgas rakuanalüüsi, geeniekspressiooni, genoomi sekveneerimist ja nukleiinhapete puhastamist.
Industry: | Pharmaceuticals (NEC) |
Grenzacherstrasse 124
BASEL
BASEL-STADT 4058
CH
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 530,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com